AutoLumo CLIA Hormonal Markers, 100 Tests

The AutoLumo CLIA Hormonal Marker Microparticles Series provides a comprehensive range of chemiluminescent immunoassay (CLIA) reagents for quantitative analysis of endocrine, thyroid, growth, metabolic, and reproductive hormones in human serum or plasma.

Utilizing magnetic microparticle-based CLIA technology, each reagent delivers high sensitivity, precision, and reproducibility on AutoLumo CLIA Analyzers, supporting accurate hormonal profiling for clinical diagnostics, fertility assessment, and endocrine disorder evaluation.

All reagents are manufactured under stringent quality standards, with CE-marked assays available for clinical compliance.

Key Features

• Comprehensive Hormone Panel: Covers thyroid, reproductive, adrenal, growth, and metabolic markers.
• Magnetic Microparticle CLIA Technology: Ensures high binding efficiency and stable signal output.
• High Sensitivity and Specificity: Detects even low-level hormonal fluctuations.
• Automation Ready: Fully compatible with AutoLumo CLIA Analyzers.
• Quantitative Precision: Excellent correlation with reference methods.
• CE Marked Kits: Selected assays validated for clinical diagnostic use.
• Long Shelf Life and Stability: Formulated for consistency and extended reagent integrity.

Product Range

Thyroid Function Markers

Endocrine Hormones

Bone Metabolism Marker

Hypertension-Related Hormones

Diabetes Markers

Growth Hormone Panel

Prenatal & Reproductive Markers

Clinical Applications

• Thyroid Function Testing: TSH, T3, T4, FT3, FT4 for thyroid disorder diagnosis and monitoring.
• Reproductive Hormone Profiling: LH, FSH, PRL, E2, PRG, and AMH for fertility and ovarian function assessment.
• Adrenal Function Evaluation: ACTH, Cortisol, and Aldosterone for adrenal disorder screening.
• Diabetes Monitoring: Insulin and C-Peptide for pancreatic beta-cell function.
• Bone Metabolism Studies: PTH and Calcitonin for calcium homeostasis evaluation.
• Growth Hormone Regulation: IGF-1 and HGH for growth disorders.
• Prenatal Screening: Free β-hCG, PAPP-A, and uE3 for maternal and fetal health assessment.

Performance Characteristics

• Detection Method: Chemiluminescent Immunoassay (CLIA)
• Technology: Magnetic Microparticle-Based Sandwich Immunoassay
• Sample Type: Human Serum or Plasma
• Precision: Coefficient of Variation (CV) ≤ 10%
• Storage: 2–8°C, protected from light
• Shelf Life: 12 months from manufacturing date

Unique Advantages

• Comprehensive coverage of major hormonal markers in one reagent platform.
• Fully automated and compatible with AutoLumo CLIA analyzers.
• Magnetic bead technology ensures enhanced sensitivity and accuracy.
• CE-marked assays available for clinical diagnostics.
• Reliable and stable performance for endocrine research and patient testing.

The AutoLumo CLIA Hormonal Marker Microparticles Series provides a complete, high-sensitivity solution for hormonal diagnostics, supporting precise measurement of thyroid, reproductive, metabolic, and growth-related hormones.

With CE-marked accuracy, automation-ready design, and broad assay coverage, it is the reagent of choice for clinical chemistry laboratories, endocrine centers, and research institutions using AutoLumo CLIA analyzers for advanced hormonal testing.